Cleared Traditional

K250301 - Merge Universal Viewer (MUV)

K250301 is the FDA 510(k) clearance for Merge Universal Viewer (MUV) by Merge Healthcare Incorporated. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 73-day FDA review.

K250301 · Merge Healthcare Incorporated · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2025
Decision
73d
Days
Class 2
Risk

K250301 is an FDA 510(k) clearance for the Merge Universal Viewer (MUV). Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Merge Healthcare Incorporated (Hartland, US). The FDA issued a Cleared decision on April 14, 2025 after a review of 73 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Merge Healthcare Incorporated devices

Submission Details

510(k) Number K250301 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 31, 2025
Decision Date April 14, 2025
Days to Decision 73 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
34d faster than avg
Panel avg: 107d · This submission: 73d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1092
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K250301.
MySpine WebPlanner
K243697 · Medacta International S.A. · Apr 2025
VersaViewer
K243651 · GE Medical Systems SCS · Apr 2025
MySegmenter (v2.0.0)
K242647 · Mysegmenter Technologies, Inc. · Apr 2025
Horos Mobile
K242552 · Icat Solutions, Ltd. · Apr 2025
brAIn™ Shoulder Positioning
K243292 · Avatar Medical · Mar 2025
Radlink GPS Pro Imaging
K242161 · Radlink, Inc. · Mar 2025